Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by NEOPTOLEMOS, J P
Right arrow Articles by SUTTON, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NEOPTOLEMOS, J P
Right arrow Articles by SUTTON, R
GUT 1998;42:886-891 ( June )

REVIEW

Acute pancreatitis: the substantial human and financial costs

J P NEOPTOLEMOS, M RARATY, M FINCH, R SUTTON

Department of Surgery,University of Liverpool,Royal Liverpool University Hospital,5th Floor UCD Block,Daulby Street, Liverpool L69 3GA, UK

Correspondence to: Professor Neoptolemos.

A greater understanding of the natural history of acute pancreatitis combined with greatly improved radiological imaging has led to improvement in the hospital mortality from acute pancreatitis, from around 25-30% to 6-10% in the past 30 years. Moreover, it is now recognised that the first phase of severe acute phase pancreatitis is a systemic inflammatory response syndrome (SIRS), during which multiple organ failure and death often supervene. Survival into the second phase may be accompanied by local complications, such as infected pancreatic necrosis, which may be prevented by prophylactic antibiotics and treated by judicious surgery. Intensive care unit costs can be substantial, but might be justified because of the excellent quality of life of survivors. Reduction in multiple organ failure by agents such as lexipafant, an antagonist of platelet activating factor (PAF) (which plays a critical role in generating the SIRS), may contribute to intensive care unit cost containment, as well as reducing the incidence of local complications and deaths from acute pancreatitis. A further improvement in the human and financial costs also requires the centralisation of the management of patients with severe acute pancreatitis, to single hospital units whose concentrated expertise equips them to intervene most effectively in what is still recognised as a highly complex disease.
(GUT 1998;42:886-891)


© 1998 by Gut



This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
W. Namkung, J. S. Yoon, K. H. Kim, and M. G. Lee
PAR2 exerts local protection against acute pancreatitis via modulation of MAP kinase and MAP kinase phosphatase signaling
Am J Physiol Gastrointest Liver Physiol, November 1, 2008; 295(5): G886 - G894.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
J Werner, S Feuerbach, W Uhl, and M W Buchler
Management of acute pancreatitis: from surgery to interventional intensive care
Gut, March 1, 2005; 54(3): 426 - 436.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. N. Criddle, M. G. T. Raraty, J. P. Neoptolemos, A. V. Tepikin, O. H. Petersen, and R. Sutton
Ethanol toxicity in pancreatic acinar cells: Mediation by nonoxidative fatty acid metabolites
PNAS, July 20, 2004; 101(29): 10738 - 10743.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
D. A O'Reilly and A. N Kingsnorth
Management of acute pancreatitis
BMJ, April 24, 2004; 328(7446): 968 - 969.
[Full Text] [PDF]


Home page
Arch SurgHome page
R. Flint and J. A. Windsor
Early Physiological Response to Intensive Care as a Clinically Relevant Approach to Predicting the Outcome in Severe Acute Pancreatitis
Arch Surg, April 1, 2004; 139(4): 438 - 443.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. L. Dugernier, P.-F. Laterre, X. Wittebole, J. Roeseler, D. Latinne, M. S. Reynaert, and J. Pugin
Compartmentalization of the Inflammatory Response during Acute Pancreatitis: Correlation with Local and Systemic Complications
Am. J. Respir. Crit. Care Med., July 15, 2003; 168(2): 148 - 157.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Bhatia, J. Slavin, Y. Cao, A. I. Basbaum, and J. P. Neoptolemos
Preprotachykinin-A gene deletion protects mice against acute pancreatitis and associated lung injury
Am J Physiol Gastrointest Liver Physiol, May 1, 2003; 284(5): G830 - G836.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M Bhatia, M Brady, J Zagorski, S E Christmas, F Campbell, J P Neoptolemos, and J Slavin
Treatment with neutralising antibody against cytokine induced neutrophil chemoattractant (CINC) protects rats against acute pancreatitis associated lung injury
Gut, December 1, 2000; 47(6): 838 - 844.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. C. C. Wagner, L. Mazzucchelli, M. Miller, A. M. Camoratto, and B. Goke
CEP-1347 inhibits caerulein-induced rat pancreatic JNK activation and ameliorates caerulein pancreatitis
Am J Physiol Gastrointest Liver Physiol, January 1, 2000; 278(1): G165 - G172.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
G. Telek, J.-Y. Scoazec, J. Chariot, R. Ducroc, G. Feldmann, and C. Rozé
Cerium-based Histochemical Demonstration of Oxidative Stress in Taurocholate-induced Acute Pancreatitis in Rats: A Confocal Laser Scanning Microscopic Study
J. Histochem. Cytochem., September 1, 1999; 47(9): 1201 - 1212.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1998 BMJ Publishing Group Ltd & British Society of Gastroenterology